Status:
COMPLETED
Ultramarathons and Impact of Phased Electromagnetic Field Therapy (PEMF)
Lead Sponsor:
Mayo Clinic
Conditions:
Healthy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This research is being done to better understand the pulmonary consequences of completing an ultra marathon at altitude and a sea level city.
Detailed Description
Subjects will be asked to undertake three (3) sets of assessments at prescribed time intervals: Baseline (at 72-24h prior to each event), immediately post (within 2h of race completion) and during rec...
Eligibility Criteria
Inclusion
- Healthy endurance trained individuals participating in the Ultra Trail du Mont Blanc (UTMB) and/or Hong Kong 100 ultramarathons
Exclusion
- \> 65 years age
Key Trial Info
Start Date :
December 12 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2021
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT03333135
Start Date
December 12 2016
End Date
June 15 2021
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905